300966.SZ
共同药业
SZSE · Healthcare · C 制造业 · CN
CNY 24.31
−3.42%Margins
Gross margin
13.8%
EBITDA margin
2.8%
EBIT margin
-15.6%
Net margin
-11.3%
FCF margin
-6.4%
-8.6%
Return on equity
-2.5%
Return on assets
-5.8%
Return on invested capital
0.22x
Asset turnover
CNY 69.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026